The combined genetic-pharmacologic strategy is appropriate for future combined deletion of two other tightly linked ADAMTS genes, Adamts8 and Adamts15, whose functions remain to be fully elucidated, both individually and in combination and are of interest since Adamts8 is implicated in pulmonary hypertension [47]. The gene discussed is ADAMTS15; the disease is pulmonary arterial hypertension.